The new report by Expert Market Research titled, ‘Global Nicotine Replacement Therapy Market Share, Report and Forecast 2022-2027’, gives an in-depth analysis of the global nicotine replacement therapy market. It assesses the market based on its segments like products, distribution channels, and major regions.
Nicotine Replacement Therapy Market Size, Trends, Industry Report, Key Player, Major Segments, and Forecast
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/nicotine-replacement-therapy-market/requestsample
The key highlights of the report include:
Market Overview (2017-2027)
• Historical Market Size (2021): USD 44.7 billion
• Forecast CAGR (2022-2027): 16.36%
• Forecast Market Size (2027): USD 109.2 billion
|Market Size in 2021||USD 44.7 billion|
|Revenue Forecast in 2027||USD 109.2 billion|
|Growth Rate CAGR||16.36%|
|Major Players||Cipla Inc., Pfizer Inc., British American Tobacco plc, Glenmark Pharmaceuticals Limited, Fertin Pharma A/S, Imperial Brands plc, Philip Morris International Inc., Japan Tobacco Inc., and Johnson and Johnson Private Limited, among others.|
The introduction of several anti-smoking awareness programmes owing to the rising fatalities caused by smoking is driving the nicotine replacement therapy market growth. In addition, the increasing awareness among the young population about the negative impacts of consuming tobacco is motivating them to quit smoking. This factor is propelling the demand for nicotine gums and inhalers.
Over the forecast period, the increasing efforts by governments to launch advertisements and introduce initiatives favouring the use of nicotine replacement therapy products are likely to bolster the nicotine replacement therapy market growth.
In terms of regions, North America accounts for a significant share in the market owing to the strong foothold of major nicotine replacement product manufacturing companies. Companies in the United States and Canada have been witnessing increased sales and are anticipated to maintain the growth in the forecast period.
Nicotine Replacement Therapy Industry Definition and Major Segments
Nicotine replacement therapy is defined as a treatment that is aimed toward reducing the intake of nicotine to curb the addiction of tobacco and cigarettes.
Nicotine is known to be a highly addictive substance, and nicotine replacement products such as gums, transdermal patches, and inhalers are used to reduce motivation to smoke. Moreover, nicotine replacement therapy also decreases the withdrawal symptoms associated with quitting nicotine.
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/nicotine-replacement-therapy-market
On the basis of product, the market can be segmented into:
• Nicotine Replacement Therapy (NRT)
o Sublingual Tablets
o Transdermal Patches
• Heat-not-burn Tobacco Products
Based on distribution channel, the nicotine replacement therapy market is bifurcated into:
The regional markets for nicotine replacement therapy include:
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
Nicotine Replacement Therapy Market Trends
The key trends in the nicotine replacement therapy market include the growing R&D activities by major market players aimed toward the production of innovative nicotine replacement products such as flavoured gums and herbal inhalers. The robust development of smartphone apps that aids users in quitting smoking through nicotine replacement products is anticipated to be a major trend in the market.
The market for nicotine replacement therapy is expected to be supported by innovations in the medical industry, the growing focus on precision medicines, and the development of new technologies to offer real-time support.
Furthermore, the growing preference of consumers toward online purchasing of nicotine replacement products is likely to bolster the market growth of nicotine replacement therapy in the forecast period.
Key Market Players
The major players in the nicotine replacement therapy market are:
- Cipla Inc
- Pfizer Inc
- British American Tobacco plc
- Glenmark Pharmaceuticals Limited
- Fertin Pharma A/S
- Imperial Brands plc
- Philip Morris International Inc
- Japan Tobacco Inc
- Johnson and Johnson Private Limited
The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Read More Reports:
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Sophia Grace, Corporate Sales Specialist – U.S.A.
Email: [email protected]
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA